Atreca, Inc. Equity Repurchase (Common, Net)

Equity Repurchase (Common, Net) of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Equity Repurchase (Common, Net) growth rates and interactive chart.


Highlights and Quick Summary

  • Equity Repurchase (Common, Net) for the quarter ending September 30, 2022 was $145 Thousand (a -1711.11% decrease compared to previous quarter)
  • Year-over-year quarterly Equity Repurchase (Common, Net) decreased by -96.69%
  • Annual Equity Repurchase (Common, Net) for 2021 was $5.5 Million (a -95.76% decrease from previous year)
  • Annual Equity Repurchase (Common, Net) for 2020 was $130 Million (a -3.37% decrease from previous year)
  • Annual Equity Repurchase (Common, Net) for 2019 was $134 Million (a 291354.35% increase from previous year)
  • Twelve month Equity Repurchase (Common, Net) ending September 30, 2022 was $8.29 Million (a -2.45% decrease compared to previous quarter)
  • Twelve month trailing Equity Repurchase (Common, Net) increased by 50.92% year-over-year
Trailing Equity Repurchase (Common, Net) for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
$8.29 Million $8.5 Million $8.54 Million $5.5 Million
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Equity Repurchase (Common, Net) of Atreca, Inc.

Most recent Equity Repurchase (Common, Net)of BCEL including historical data for past 10 years.

Interactive Chart of Equity Repurchase (Common, Net) of Atreca, Inc.

Atreca, Inc. Equity Repurchase (Common, Net) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.15 $-0.01 $3.77
2021 $4.39 $0.35 $0.03 $0.73 $5.5
2020 $0.72 $127.34 $0.54 $0.96 $129.55
2019 $0.05 $0.15 $133.85 $0.01 $134.07
2018 $0.02 $0.01 $0.05

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology